Buzz Stocks: Twitter Inc, Finish Line Inc, and Merrimack Pharmaceuticals Inc

Today's stocks to watch in the news include Twitter Inc (NYSE:TWTR), Finish Line Inc (NASDAQ:FINL), and Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

Dec 21, 2016 at 9:28 AM
facebook X logo linkedin


U.S. stock futures are trading above fair value, ahead of another day light of economic news. Among specific equities in the spotlight today are social media stock Twitter Inc (NYSE:TWTR),  retail interest Finish Line Inc (NASDAQ:FINL), and biotech Merrimack Pharmaceuticals Inc (NASDAQ:MACK). Here's a quick look at what's driving TWTR, FINL, and MACK.

  • TWTR is down 1% in electronic trading, following news two more executives are leaving the company, including its chief technology officer. The shares have been sliding since bumping into their 320-day moving average earlier this month, and, at $17.92, have lost 22.6% in 2016. Nonetheless, Twitter Inc call options have remained extremely popular in recent weeks. The stock's 10-day call/put volume ratio at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) comes in at 3.98, which tops three-fourths of all comparable marks from the past year. 

  • FINL is set to get hit hard this morning, with the shares down 15% in pre-market action, after the company reported weak third-quarter sales and a disappointing outlook. No brokerage firms have yet to weigh in, but there is potential for downgrades, with six analysts rating the stock a "strong buy." Then again, the expected pullback would put Finish Line Inc in the $19.50 range, an area that acted as strong support last month. And it's not like FINL was underperforming, as the stock had added more than 27% year-to-date, going by last night's close at $23.01. 

  • MACK is down 9.6% ahead of the open, after the company said it was halting a drug trial for its breast cancer treatment, since an independent panel suggested it would not outperform similar treatments. Shares of Merrimack Pharmaceuticals Inc have been grinding lower since their April 2015 peak near $14, closing Tuesday at $5.37. The stock is heavily shorted, however, so not everyone would be a loser if today's sell-off comes to fruition. In fact, nearly one-third of MACK's float is sold short, which equates to more than 18 days' worth of buying power, based on average daily volumes. 

Stay on top of overnight news & big morning movers. Sign up now for Schaeffer's Opening View.

 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI